• Fund Type: Closed-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Tekla Life Sciences Investors

+ Add to Watchlist

HQL:US

26.0800 USD 0.2900 1.10%

As of 20:04:04 ET on 12/19/2014.

Snapshot for Tekla Life Sciences Investors (HQL)

Open: 26.3700 High - Low: 26.5400 - 26.0700 Primary Exchange: New York
Volume: 101,393 52-Week Range: 18.9745 - 26.5400 Beta vs NBI: 0.8522

ETF Chart for HQL

No chart data available.
  • HQL:US 26.0800
  • 1D
  • 1M
  • 1Y
26.3700
Interactive HQL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for HQL

Tekla Life Sciences Investors is a diversified, closed-end management investment company incorporated in the USA. The Fund's objective is long-term capital appreciation. The Fund invests mainly in securities of life sciences companies and primarily in securities of public and private companies that are believed to have significant potential for above-average growth.

Inception Date: 1992-05-08 Telephone: 1-617-772-8500
Managers: DANIEL R OMSTEAD
Web Site: www.teklacap.com

Fundamentals for HQL

NAV (on 2014-12-19) 26.1900
Assets (M) (on 2014-12-19) 497.7390
Shares out (M) 19.01
Market Cap (M) 495.67
% Premium -0.42
Average 52-Week % Premium -2.5980
Fund Leveraged N

Dividends for HQL

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net (on 2014-11-24) 0.4700
Dividend Yield (ttm) 6.68%

Performance for HQL

1-Month +7.52% 1-Year +43.42%
3-Month +18.93% 3-Year +43.78%
Year To Date +42.01% 5-Year +34.94%
Expense Ratio 1.32

Top Fund Holdings for HQL

Filing Date: 09/30/2014
Name Position Value % of Total
Gilead Sciences Inc 563,820 60,018,639 13.515%
Celgene Corp 436,322 41,354,599 9.312%
Vertex Pharmaceuticals Inc 206,557 23,198,417 5.224%
Alexion Pharmaceuticals Inc 127,799 21,191,630 4.772%
Regeneron Pharmaceuticals Inc 54,522 19,656,271 4.426%
Amgen Inc 136,594 19,185,993 4.320%
Biogen Idec Inc 54,182 17,923,947 4.036%
Incyte Corp 259,915 12,748,831 2.871%
Actavis plc 46,815 11,295,523 2.544%
Shire PLC 37,379 9,683,030 2.180%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil